26 research outputs found

    Review on Current Sheets in CME Development: Theories and Observations

    Get PDF

    Large-Eddy Simulations of Magnetohydrodynamic Turbulence in Heliophysics and Astrophysics

    Get PDF
    We live in an age in which high-performance computing is transforming the way we do science. Previously intractable problems are now becoming accessible by means of increasingly realistic numerical simulations. One of the most enduring and most challenging of these problems is turbulence. Yet, despite these advances, the extreme parameter regimes encountered in space physics and astrophysics (as in atmospheric and oceanic physics) still preclude direct numerical simulation. Numerical models must take a Large Eddy Simulation (LES) approach, explicitly computing only a fraction of the active dynamical scales. The success of such an approach hinges on how well the model can represent the subgrid-scales (SGS) that are not explicitly resolved. In addition to the parameter regime, heliophysical and astrophysical applications must also face an equally daunting challenge: magnetism. The presence of magnetic fields in a turbulent, electrically conducting fluid flow can dramatically alter the coupling between large and small scales, with potentially profound implications for LES/SGS modeling. In this review article, we summarize the state of the art in LES modeling of turbulent magnetohydrodynamic (MHD) ows. After discussing the nature of MHD turbulence and the small-scale processes that give rise to energy dissipation, plasma heating, and magnetic reconnection, we consider how these processes may best be captured within an LES/SGS framework. We then consider several special applications in heliophysics and astrophysics, assessing triumphs, challenges,and future directions

    Modelling Quasi-Periodic Pulsations in Solar and Stellar Flares

    Full text link

    Infection with toxin a-negative, toxin b-negative, binary toxin-positive clostridium difficile in a young patient with ulcerative colitis

    No full text
    Large clostridial toxin-negative, binary toxin-positive (A- B- CDT+) strains of Clostridium difficile are almost never associated with clinically significant C. difficile infection (CDI), possibly because such strains are not detected by most diagnostic methods. We report the isolation of an A- B- CDT+ ribotype 033 (RT033) strain of C. difficile from a young patient with ulcerative colitis and severe diarrhea

    The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation

    No full text
    BackgroundThe health hazards of smoking are significant and well established. Giving up smoking is difficult and therefore needs to be treated as a chronic, but potentially curable, illness. Nicotine replacement therapy (NRT) and bupropion sustained-release formulation (SR) (Zyban®) are two pharmacological agents available to aid smokers in their attempts to achieve smoking cessation.ObjectivesThe aim of this review was to assess the clinical effectiveness, cost-effectiveness and adverse effects of bupropion SR and NRT for smoking cessation. The effects of therapy in assisting long-term reduction in the amount smoked by smokers who are unwilling or unable to quit were not assessed.MethodsSearch strategyTwenty-six electronic databases and Internet resources were searched from inception to May 2001. In addition, the bibliographies of retrieved articles and submissions received from the manufacturers were searched.Inclusion and exclusion criteriaTwo reviewers independently screened all titles and abstracts for relevance and made final decisions regarding the inclusion and exclusion criteria of studies based on full paper copies of manuscripts. Studies were assessed according to predefined criteria. Any discrepancies were resolved by consensus and, where necessary, a third reviewer was consulted. Only systematic reviews and newly identified randomised controlled trials (RCTs) of bupropion SR (used alone or as part of a combination therapy with motivational support or motivational support and NRT) or any type of NRT were included in the review of clinical effectiveness. Participants included smokers of any age or gender and studies had to report abstinence (preferably continued rather than point abstinence) as an outcome measure. In addition, the assessment of adverse effects also included non-RCTs, case-controlled studies, uncontrolled studies and surveillance studies, the primary objective of which was the investigation of the adverse effects, tolerability or safety of bupropion SR or bupropion immediate-release (IR) and/or NRT. Case reports and case series were also documented. The economic assessment included evaluations of the cost-effectiveness or cost–utility of bupropion SR and/or NRT.Data extraction strategyData were extracted into an Access database by one reviewer and checked by a second reviewer. Any disagreements were resolved through discussion.Quality assessment strategyThe quality of each study was assessed using predefined criteria specified according to study design. The assessment was performed by one reviewer and checked by a second reviewer. Disagreements were resolved through consensus and, if necessary, a third reviewer was consulted.Analysis strategyStudy details, validity and data were reported in structured tables and discussed in the text of the review. For the assessment of clinical effectiveness, where available and appropriate, pooled estimates of effect in the form of odds ratios from systematic reviews are presented. Subgroup and sensitivity analyses are reported where data are available. For the assessment of adverse events and safety the summary was mainly a narrative one. In the assessment of cost effectiveness, evaluations were grouped according to design.ResultsIncluded studiesA total of 157 studies were included in the review. These comprised three systematic reviews and 13 individual studies of effectiveness; four systematic reviews and 112 individual studies relating adverse events and safety; and 17 economic studies.Quality of clinical-effectiveness dataThe quality of the systematic reviews and individual RCTs included in the review was good.Quality of adverse-effects dataThe nature and quality of the adverse-effect and safety data were very variable. In particular, many of the studies were uncontrolled, with all the inherent weaknesses of such studies. Furthermore, many of the uncontrolled studies were small, but many of the larger ones suffered from poor quality of reporting. Interpretation of surveillance data was limited by a lack of information on the size of the population treated.Assessment of clinical effectivenessThe effectiveness of NRT as an aid to smoking cessation has been thoroughly investigated. The evidence indicates unequivocally that NRT as an aid to smoking cessation is more effective than placebo. The majority of the data come from studies investigating the use of NRT gum and NRT patches. Despite this, there are no data to indicate that other forms of NRT are less efficacious. There are no data to indicate sub-group differences in the response to NRT.There is clear evidence that bupropion SR is more effective than placebo. There is evidence from single subgroup populations that bupropion SR is as effective in smokers with chronic obstructive pulmonary disease, cardiovascular disease, and those who have failed in the past to achieve abstinence with bupropion SR, as in the general smoking population.Evidence to support the superiority of bupropion SR over NRT for smoking cessation is relatively weak, with one double-blind study indicating that the NRT patch is less effective than bupropion SR and another unblinded study finding no difference between NRT gum and bupropion SR. Further double-blind RCTs are required.Assessment of adverse events and safetyOverall, the incidence of adverse events with NRT is very low. The main concern relates to potential adverse cardiovascular effects (i.e. the same harmful effects that are the driving force behind needing to ‘treat’ smoking as a chronic illness). There is strong evidence that the effects of nicotine acquired through NRT are no different from those of smoking-derived nicotine. Evidence suggests that the main problem with NRT is that its use can delay the reversal of the adverse effects of smoking normally associated with smoking cessation. There is evidence to suggest that the abuse potential of NRT is low.There is only very limited overlap of adverse symptoms associated with the different types of NRT. Thus, the qualitative differences of the adverse effects associated with the different types of NRT will determine their effectiveness in different individuals.None of the common adverse events of bupropion (rash and pruritus, irritability, insomnia, dry mouth, headache, tremor, urticaria) reported in this review are newly identified. The adverse events resulting in withdrawal from treatment with bupropion SR are the same as those for the IR formulation (skin disorders (mainly rash), insomnia, tremor, headache, dry mouth, anxiety), with the exception of motor disturbances, psychological problems, drowsiness, weight loss, headache/nasal congestion, thinking difficulties, dizziness and tachycardia/palpitations. Such differences might be due to differences in dose and duration of treatment, and differences in response between depressed and non-depressed patients. Significantly, the side-effect profile of bupropion SR does appear to be better than that of the IR formulation.Assessment of cost-effectivenessPublished economic studies of smoking cessation have adopted different methods and assumptions for estimating effectiveness and costs. However, the results of existing economic evaluations consistently indicate that smoking cessation interventions are relatively cost-effective in terms of the cost per life-year saved. An assessment of results from existing studies suggests that the number of life-years saved per quitter ranges from 1.0 to 3.0. Adding NRT to current practice is cost-effective, with a relatively low (under £1000) incremental cost per quitter. No published studies have evaluated the relative cost-effectiveness of bupropion SR for smoking cessation.A decision analysis model has been built to compare the cost-effectiveness of four smoking cessation interventions:advice or counselling only (including general practitioner advice and more intensive counselling by other health professionals) advice plus NRTadvice plus bupropion SRadvice plus NRT and bupropion SR.The results of this decision analysis modelling are broadly similar to those found in previous studies. NRT and/or bupropion SR as smoking-cessation interventions are cost-effective as compared with many accepted healthcare interventions. According to our estimates, the incremental cost per life-year saved is about £1000–2400 for NRT, £640–1500 for bupropion SR and £900–2000 for NRT plus bupropion SR.The estimated cost of the smoking-cessation programme to the NHS in England and Wales would be about £67 to 202 million per year. Consequently, about 45,000–135,000 smokers would quit, and 90,000–270,000 life-years may be saved. The average cost per life-year is about £750 (range £500–1500).The incremental cost-effectiveness of bupropion SR is generally better than that of NRT. However, this should be interpreted cautiously because of the very limited available data on the relative efficacy of bupropion SR and because the cost of adverse effects of bupropion SR were not considered in the analysis.ConclusionsBoth NRT and bupropion SR are effective interventions to assist smoking cessation. The relative effectiveness of bupropion SR and NRT still needs further research. Information on how to maximise effectiveness in practice is still lacking, but motivational support is probably involved. The most significant differences between NRT and bupropion SR relate to the adverse events and safety profiles of these interventions. Overall, the safety profile of NRT is more favourable, particularly given the small but real risk of seizure with bupropion SR. Irrespective of the methods used or the assumptions involved, the results of existing economic evaluations and the model developed in this review consistently suggest that smoking-cessation interventions, including the use of NRT and/or bupropion SR, are relatively cost-effective in terms of the cost per life-year saved. The worst-case scenarios still provide estimates of cost-effectiveness better than many other medical interventions

    Procedural justice in carbon capture and storage

    No full text
    This paper examines where and how claims of procedural injustice, or demands for procedural justice, might arise with respect to carbon capture and storage (CCS), taking a broad view of the CCS research, development and deployment process. It considers the principles that might govern such claims and seeks to identify where responsibility might lie for ensuring justice, or addressing contested claims of injustice. It is suggested that claims of procedural injustice arising from CCS are most likely to arise during implementation, from locally affected populations, raising concerns of inadequate information or consultation; but they may also arise from representatives of other indirectly affected groups, such as those affected by upstream impacts of coal mining, or energy market consequences of CCS policy. It is further suggested that claims are most likely to be directed at public authorities in respect of decisions over policy, strategy or authorisations for individual developments, but there are also routes by which claims may be directed at the corporations involved, especially under human rights provisions. The paper suggests a need for careful consideration of both procedural and, by implication, distributive justice matters in the emerging regulatory and support framework for CCS, with a particular imperative for moving public engagement upstream prior to deployment and indeed even to research programmes, to maximise the scope for legitimate influence on future outcomes

    Avaliação por fotointerpretação das áreas de abrangência dos diferentes estados da erosão acelerada do solo em canaviais e pomares de citros Evaluation of areas of different states of accelerated erosion of soil in sugar cane plantations and citrus orchards utilizing photointerpretation techniques

    No full text
    Este estudo foi realizado com o objetivo de avaliar os estados de erosão acelerada do solo presente em áreas com canaviais e pomares de citros localizados na região administrativa de Ribeirão Preto - SP. Foram empregadas fotografias aéreas verticais, na escala aproximada de 1:40.000, do vôo da cobertura aerofotográfica da região citrícola do Estado de 1988. O estudo foi realizado identificando-se e delimitando-se todas as áreas de abrangência de cinco estados da erosão acelerada do solo presentes nos canaviais e pomares de citros. A presença da erosão acelerada severa a extremamente severa foi constatada tanto nos canaviais como nos pomares de citros, nas quatro unidades de solos de ocorrências principais na área de estudo. Os valores da extensão total das áreas de abrangência dos estados da erosão 2 a 5 (processos erosivos intensos a extremamente intensos) revelaram forte impacto sobre o desenvolvimento das culturas, degradando o solo agrícola e afetando a qualidade da água. As principais diferenças, quanto à extensão total das áreas de abrangência dos diferentes estados da erosão presente, foram identificadas principalmente entre os Argissolos e os Latossolos, e entre os dois estágios de desenvolvimento das culturas. As condições de solo exposto foram verificadas nas áreas recentemente plantadas com cana-de-açúcar ou citros, explicitando-se a grande necessidade de empregar, nessas condições, práticas conservacionistas.<br>This study was conducted with the objective of evaluating the states of accelerated erosion of soil in areas with sugar cane and citrus orchards located in Ribeirão Preto - SP, Brazil, using photointerpretation techniques. Vertical aerial photos, scale of 1:40.000 from the aerophotographic covering of the citric area of the State in 1988 have been used. The map of the land used and accelerated erosion was made in all the areas with five states of the soil accelerated erosion present in the sugar cane plantations and citrus orchards. The study showed the presence of a serious problem caused by the accelerated erosion in the sugar cane plantations and citrus orchards. The presence of areas of severe to extremely severe erosion was verified in the sugar cane plantations and in the citrus orchards, in four soil units, in the study area. The values of the total extension of the areas of the states of erosion 2 to 5 (intense to extremely intense erosive processes) revealed a strong impact of the accelerated erosion on the development of the cultures. This can cause a degradation of the agricultural land and can affect the distribution and quality of the water. The conditions of exposed soil were verified in the areas recently planted with sugar cane or citrus, and those conditions need better agricultural management
    corecore